Clinical trial Recruiting at 3 sites Interventional Ages 22 and up

Breathing-linked pacemaker pacing after bypass surgery for heart failure with reduced ejection fraction

Official title: Respiratory Sinus Arrhythmia Pacing Post-CABG Surgery in Patients With HFrEF

Run by Ceryx Medical Ltd · NCT06384963 · Data updated 2026-11-12

This will test a pacemaker setting that restores the heart's natural breathing-linked rate in people with reduced ejection fraction after bypass surgery to see if it is safe and improves heart function.

Quick facts

Study typeInterventional
Ages22 Years and up
SexAll
Enrollment54 (estimated)
SponsorCeryx Medical Ltd
Industry-sponsored
Locations3 sites (Adelaide, South Australia and 2 other locations)
StatusRecruiting
StartedSeptember 2, 2024
Main results expectedMarch 1, 2026
Study endsApril 1, 2026
Registry record updatedJuly 22, 2025
Trial IDNCT06384963 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 22 or older with HFrEF (left ventricular EF 20–40%), in sinus rhythm, scheduled for isolated on-pump CABG including the left anterior descending artery, and able to give informed consent are the intended participants.

Probably not a fit

Patients with atrial fibrillation or flutter, an existing pacemaker or defibrillator, emergency or off-pump CABG, intrinsic resting heart rate over 100 bpm, pregnancy, or inability to consent are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This first-in-human, multicentre, randomized controlled trial compares respiratory sinus arrhythmia (RSA)–modulated atrial pacing to standard monotonic atrial pacing in patients with HFrEF undergoing on-pump CABG. Participants receive the assigned pacing for up to 10 days while monitored closely in hospital, with baseline testing before surgery and a phone follow-up at one month. The primary outcome is safety measured by arrhythmia episodes, and secondary outcomes include measures of cardiac function, cardiac output, and apnoea episodes. The trial aims to see whether restoring breathing-linked heart rate variability improves short-term postoperative cardiac performance without increasing risk.

Why it matters

Potential benefit: If successful, RSA pacing could improve cardiac output and short-term recovery after CABG for people with HFrEF while maintaining typical pacemaker safety.

How similar studies have gone: This is a first-in-human test of RSA pacing: animal studies suggested improved cardiac function but human data are currently lacking.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients (≥ 22 years) selected for isolated, on-pump coronary artery bypass graft (CABG)
* Established diagnosis of heart failure with reduced ejection fraction (HFrEF).
* Elective or urgent admission routes
* Echocardiography assessment of left ventricular ejection fraction (EF) of 20%-40% (within 1 month of planned surgery)
* Sinus rhythm
* Any number of coronary vessels replaced. Must include left anterior descending artery.
* Able to provide written informed consent

Exclusion Criteria:

* Requirement for concurrent valve replacement surgery.
* Off-pump CABG.
* Emergency CABG
* History of paroxysmal or permanent atrial fibrillation or flutter
* History of atrioventricular-node dependent tachycardia
* Patients lacking capacity to consent
* Patient testing positive for Covid-19 within 14 days of intended CABG (PCR or lateral flow test)
* Intrinsic resting heart rate \> 100bpm
* Pregnancy
* Implanted pacemaker or defibrillator
* Failure to obtain Uscom signals

Where it's running

  • Royal Adelaide Hospital
    Adelaide, South Australia, Australia
    Recruiting
  • Monash Health
    Melbourne, Victoria, Australia
    Recruiting
  • Waikato Hospital
    Hamilton, New Zealand
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.